相关实验视频
Updated: Jul 28, 2025

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
脂蛋白阿费雷斯:当前治疗家族高胆固醇血症和高脂蛋白的建议 (a)
Maya S Safarova1, Patrick M Moriarty2
1Department of Cardiovascular Medicine, University of Kansas Hospital and Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA. msafarova@kumc.edu.
在患有家族性高胆固醇血症 (FH) 和高脂质蛋白 (Lp) 的患者中,脂质蛋白异位有效降低胆固醇. 这种安全的程序降低了动脉样硬化心血管疾病 (ASCVD) 的风险,并改善了长期的结果.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 家庭性高胆固醇血症 (FH) 和高脂蛋白血症 (a) 显著增加动脉样硬化心血管疾病 (ASCVD) 的风险.
- 基于电子健康记录的策略和遗传检测可以改善遗传性脂质疾病的检测和管理.
- 脂质蛋白疏散是特定脂质疾病的关键治疗选择.
研究的目的:
- 批判性地审查目前关于FH和升高脂蛋白 (Lp) 的脂蛋白异位的证据.
- 总结脂蛋白异位症在治疗遗传性脂质疾病中的好处和挑战.
主要方法:
- 系统审查可用关于脂质蛋白非的疗效和安全性的数据.
- 对在患有FH和升高Lp (a) 的患者中报告脂质蛋白非结局的研究分析.
主要成果:
- 脂质蛋白疏松迅速减少了超过60%的异原性脂质蛋白,显著降低了ASCVD事件的风险.
- 它改善了血液类风湿学,内皮功能,并减少了炎症标志物.
- 结合的降脂疗法可以增强非雷斯疗效,而注册会提供真实数据.
结论:
- 脂蛋白非瑞斯是一种安全有效的治疗方法,用于降低FH和升高Lp的胆固醇.
- 它减少了ASCVD的负担,并改善了患者的长期预后.
- 多学科的团队方法对于成功的应用程序管理至关重要.
更多相关视频
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
10:56A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Lipids: Dietary Sources and Requirements
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...